Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 3 1Phase 2/3 1

Status

Completed 27Recruiting 20Unknown 18Terminated 7Not yet recruiting 7Active not recruiting 6Withdrawn 2

Sponsor Class

OTHER 6NIH 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Gastrointestinal 4Tumor-Agnostic 1Head & Neck 1

Conditions

Barrett Esophagus 2Adenocarcinoma Of Esophagus 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pathologic Complete Response 1Disease 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Carcinoma 1

Interventions

Cisplatin 122Carboplatin 121Drug Therapy 118Bevacizumab 105Capecitabine 99Oxaliplatin 97Radiotherapy 95Paclitaxel 88Gemcitabine 88tislelizumab 87Cyclophosphamide 86Specimen Handling 80pembrolizumab 76toripalimab 67Magnetic Resonance Spectroscopy 65Fluorouracil 62sintilimab 59Injections 57Surgical Procedures, Operative 56Docetaxel 54anlotinib 51130-nm albumin-bound paclitaxel 48Immune Checkpoint Inhibitors 47fludarabine 46Standard of Care 45Pemetrexed 43Blood Specimen Collection 43Biopsy 43venetoclax 41lenvatinib 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Not yet recruiting × Endoscopy × Clear all
NCT06732388 2026-05-13

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

National Cancer Institute (NCI)

Phase 2 Not yet recruiting
64 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT07445828 2026-04-30

Lynch syndrome

Region Skane

Not yet recruiting
78 enrolled
Gastrointestinal

Colorectal Neoplasms, Hereditary Nonpolyposis

NCT07206589 2026-04-17

Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial

Mayo Clinic

Phase NA Not yet recruiting
1,010 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting
394 enrolled

Pathologic Complete Response

NCT07392580 2026-02-06

Intralesional Chemotherapy (IC): Cisplatin + Epinephrine

University of Miami

Phase 2 Not yet recruiting
20 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07323186 2026-01-07

NEOTOGAS

Nantes University Hospital

Phase NA Not yet recruiting
100 enrolled
Gastrointestinal

Disease, Stomach Neoplasms

NCT05144100 2021-12-03

SCOPE

Tata Memorial Centre

Phase 2/3 Not yet recruiting
498 enrolled
Tumor-Agnostic

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡